Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 7/20 | 0.38 |
| ▸ | CES1 | P23141 | 5/20 | 0.38 |
| ▸ | CES2 | O00748 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13303098 | 1.00 | DNM1 (0.48) | DNM1TSHRTHRBFAAHCES1 | |
| SCHEMBL13303192 | 0.89 | DNM1 (0.33) | DNM1TSHRTHRBFAAHCES1 | |
| Bicarbonate SCHEMBL4226376 | 0.89 | FAAH (0.45) | TSHRFAAHCES1CES2MEN1 | |
| SCHEMBL22532181 | 0.76 | DNM1 (0.43) | DNM1TSHRTHRBFAAHCES1 | |
| SCHEMBL3339446 | 0.74 | — | — | |
| SCHEMBL4605368 | 0.74 | DNM1 (0.48) | DNM1TSHRTHRBFAAHCES1 | |
| SCHEMBL28136332 | 0.72 | DNM1 (0.46) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL439341 | 0.72 | DNM1 (0.46) | DNM1TSHRTHRBMEN1KMT2A | |
| SCHEMBL3538819 | 0.72 | DNM1 (0.46) | DNM1TSHRTHRBMEN1KMT2A | |
| SCHEMBL3534539 | 0.72 | DNM1 (0.46) | DNM1TSHRTHRBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090320718-A1 | FLUOROSURFACTANTS | MERCK PATENT GESELLSCHAFT (DE) | 2009-12-31 | — | — | US | disclosed |
| EP-2035132-A2 | FLUOROSURFACTANTS | MERCK PATENT GmbH (DE) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008003447-A2 | FLUOROSURFACTANTS | MERCK PATENT GMBH (DE) | 2008-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090320718-A1 | FLUOROSURFACTANTS | FPR3, Q6ZSR9, SGMS2 | DNM1 1389/4885TSHR 2505/4885THRB 4234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.